| [1] |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015[J]. CA Cancer J Clin, 2015, 65(1): 5-29.
|
| [2] |
Patten DK, Sharifi LK, Fazel M. New approaches in the management of male breast cancer[J]. Clin Breast Cancer, 2013, 13(5): 309-314.
|
| [3] |
Kaushik M, Olivera-Cunha M, Shokuhi S. Male breast cancer: a single centre experience and current evidence[J]. Breast J, 2014, 20(6): 674-675.
|
| [4] |
Siegel R, Naishadham D, Jemal A. Cancer statistics[J]. CA Cancer J Clin, 2012, 62(1): 10-29.
|
| [5] |
Krause W. Male breast cancer-an andrological disease: risk factors and diagnosis[J]. Andrologia, 2004, 36(6): 346-354.
|
| [6] |
Ruddy KJ, Winer EP. Male breast cancer: risk factors, biology diagnosis, treatment, and survivorship[J]. Ann Oncol, 2013, 24(6): 1434-1443.
|
| [7] |
Sas-Korczynska B, Adamczyk A, Niemiec J, et al. Androgen receptor in male breast cancer[J]. Pol J Pathol, 2015, 66(4): 347-352.
|
| [8] |
Vaysse C, Sroussi J, Mallon P, et al. Prediction of axillary lymph node status in male breast carcinoma[J]. Ann Oncol, 2013, 24(2): 370-376.
|
| [9] |
Mauer C, Martel S, Azambuja Ede. Male breast cancer: finding the way in this uncommon path[J]. ESMO Open, 2017, 2(1): e000169.
|
| [10] |
Korde LA, Zujewski JA, Kamin L, et al. Multidisciplinary meeting on male breast cancer: summary and research recommendations[J]. J Clin Oncol, 2010, 28(12): 2114–2122.
|
| [11] |
Murphy CE, Carder PJ, Lansdown MRJ, et al. Steroid hormone receptor expression in male breast cancer[J]. Eur J Surg Oncol, 2006, 32(1): 44-47.
|
| [12] |
Farrow JH, Adair FE. Effect of orchidectomy on skeletal metastases from cancer of the male breast[J]. Science, 1942, 95(95): 654.
|
| [13] |
Hotko YS. Male breast cancer: clinical presentation, diagnosis, treatment[J]. Exp Oncol, 2013, 35(4): 303-310.
|